| 4d ago | DJ | Novartis Considers Possible Bid for Actavis |
| 4d ago | DJ | Pair of Studies Show Power of Immune System to Fight Cancer |
| 4d ago | | PFIZER INC.: StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX |
| 6d ago | | PFIZER INC.: Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at t.. |
| 05/10 | DJ | Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl |
| 05/10 | | Drugmakers face more scrutiny of discordant U.S. prices |
| 05/10 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 05/10 | DJ | PAIN THERAPEUTICS: Pfizer Reassessing Continued Remoxy Partnership |
| 05/08 | | PFIZER INC.: Pfizer Invites Public to View and Listen to Webcast of Pfizer Pres.. |
| 05/08 | | U.S. COMPANIES' OVERSEAS EARNINGS HI: study |
| 05/08 | | PFIZER INC.: ex-dividend day |
| 05/07 | DJ | WebMD First-Quarter Loss Narrows; Chief Executive to Step Down |
| 05/07 | DJ | U.S. Stocks Hit New Highs as Global Rally Continues |
| 05/07 | | PFIZER INC.: Accelrys and Pfizer Extend Agreement for Global Deployment of Scie.. |
| 05/06 | | PFIZER INC.: Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE .. |
| 05/06 | | PFIZER INC.: Facing Off Against Counterfeit Online Pharmacies: Pfizer Launches .. |
| 05/03 | | Insider-trading trial of SAC Capital's Steinberg to start November 18 |
| 05/01 | DJ | Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity |
| 05/01 | DJ | Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity |
| 05/01 | DJ | Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity |
| 05/01 | DJ | Merck Net Dips 8%, OKs $15 Billion Stock Buyback |
| 05/01 | DJ | Merck 1st-Quarter Profit Off 8.3% Amid Loss of Singular Exclusivity |
| 04/30 | | Expert network firm hires Texas-based SEC lawyer |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stocks Tally April Gains; S&P 500 Hits Record |
| 04/30 | | Pfizer results fall short; company trims profit forecast |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stock Indexes Ready For April Gains |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stock Indexes Ready For April Gains |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stock Indexes Ready For April Gains |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stocks Lower; Pfizer Weighs On Dow |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stocks Mostly Lower; Pfizer Weighs On Dow |
| 04/30 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 04/30 | DJ | Pfizer 1st-Quarter Profit Up 53% on One-Time Gains; Co Cuts 2013 Outlook |
| 04/30 | DJ | Pfizer Profit Up 53% on One-Time Gains |
| 04/30 | DJ | Pfizer 1st-Quarter Profit Up 53% on One-Time Gains; Cuts 2013 Outlook |
| 04/30 | | PFIZER INC.: Pfizer Reports First-Quarter 2013 Results |
| 04/30 | DJ | Pfizer 1st-Quarter Profit, Sales Miss Estimates as Lipitor Pressure Continues |
| 04/30 | DJ | MARKET SNAPSHOT: U.S. Stocks Trim April Gains, But Tech Shines |
| 04/30 | DJ | Pfizer 1st-Quarter Profit Up 53%; Cuts 2013 Outlook |
| 04/29 | DJ | Protalix BioTherapeutics Treatment for Gaucher Disease Approved in Mexico, Ch.. |
| 04/29 | DJ | Merck and Pfizer Agree to Develop Type 2 Diabetes Treatment |
| 04/29 | | PFIZER INC.: Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreeme.. |
| 04/28 | DJ | MARKET SNAPSHOT: Data To Overtake Earnings As May Looms |
| 04/28 | | PFIZER INC.: Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar.. |
| 04/27 | | WALL STREET WEEK AHEAD: Central banks, data to steer investors |
| 04/26 | DJ | WEEK AHEAD: Facebook Earnings, Fed Meeting, April Payroll Data |
| 04/26 | DJ | As Biotechnology Stocks Soar, Bubble Talk Percolates |
| 04/26 | | EU body backs new Roche, Astellas, Sanofi, Vivus drugs |
| 04/26 | DJ | U.S. Stocks Edge Mostly Lower |
| 04/26 | DJ | U.S. Stocks Open Mostly Lower After Data -2- |
| 04/26 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 04/25 | DJ | PFIZER INC.: European Committee Recommends Against Approval of Pfizer Rheumatoi.. |
| 04/25 | | PFIZER INC.: Pfizer Receives CHMP Negative Opinion Regarding Marketing Authoriz.. |
| 04/25 | | PFIZER INC.: Pfizer Hosts Annual Meeting Of Shareholders |
| 04/25 | DJ | Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales |
| 04/25 | DJ | Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales |
| 04/25 | DJ | Bristol-Myers Net Drops on Lower Heart Drug Sales |
| 04/25 | DJ | PFIZER INC.: Pfizer : Celebrex Meets Goals in Juvenile Rheumatoid Arthritis Stu.. |
| 04/25 | | PFIZER INC.: Top-Line Data Show Celecoxib Met Primary Objective In Clinical Tri.. |
| 04/25 | DJ | Bristol-Myers 1st-Quarter Net Drops 45% on Lower Sales of Heart Drugs |
| 04/24 | | Analysts see possible windfall from GSK spin-offs |
| 04/24 | DJ | FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug |
| 04/23 | DJ | FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug |
| 04/22 | | Moody's sees pick-up in pharmaceutical industry M&A in 2013 |
| 04/22 | DJ | Glaxo in Drug-Discovery Venture Capital Deal |
| 04/18 | | PFIZER INC.: Brower Piven Encourages Investors Who Purchased 20,000 or More Sha.. |
| 04/18 | | PFIZER INC.: Pfizer Invites Public To Listen To Webcast Of April 25 Annual Meet.. |
| 04/18 | DJ | Merck CEO Pay Rises but Still Nicked by Research Setbacks |
| 04/18 | | Nestle sees growth at lower end of guidance in 2013 |
| 04/18 | | Mideast unrest, cold weather hit Nestle sales growth |
| 04/16 | | ING U.S. IPO could value company at over $6 billion |
| 04/16 | DJ | ING U.S. Sees 64 Million-Share IPO Raising Up to $1.5 Billion |
| 04/16 | DJ | ING U.S. Sees 64 Million-Share IPO Raising Up to $1.5 Billion |
| 04/16 | | Judge conditions $602 million SAC settlement on appeals court |
| 04/16 | DJ | J&J 1st-Quarter Profit Off 11% on Litigation Expenses, Acquisition-Related It.. |
| 04/15 | | Citi profit rises 30 percent as investment banking grows |
